Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | HMGCR | P04035 | 1/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.36 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.36 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.36 |
| ▸ | CPT2 | P23786 | 2/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | ACLY | P53396 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 2/20 | 0.33 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.33 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | GABRP | O00591 | 1/20 | 0.32 |
| ▸ | GABRD | O14764 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3667247 | 0.90 | CYP2D6 (0.35) | CYP2D6TSHRCYP2C19HIF1AALDH1A1 | |
| SCHEMBL10654543 | 0.89 | BLM (0.39) | CYP2D6TSHRCYP2C19HIF1AALDH1A1 | |
| SCHEMBL8557803 | 0.86 | HSPD1 (0.45) | TSHRALDH1A1CPT2FFAR1TDP1 | |
| SCHEMBL7710974 | 0.86 | FFAR1 (0.41) | CYP2D6TSHRCYP2C19HIF1AALDH1A1 | |
| SCHEMBL2816326 | 0.85 | BLM (0.50) | CYP2D6TSHRCYP2C19HIF1ACPT2 | |
| SCHEMBL4716771 | 0.85 | BLM (0.50) | CYP2D6TSHRCYP2C19HIF1ACPT2 | |
| SCHEMBL9956582 | 0.84 | FFAR1 (0.44) | CYP2D6TSHRCYP2C19HIF1ACPT2 | |
| SCHEMBL9955921 | 0.84 | FFAR1 (0.44) | CYP2D6TSHRCYP2C19HIF1ACPT2 | |
| SCHEMBL9954618 | 0.84 | FFAR1 (0.44) | CYP2D6TSHRCYP2C19HIF1ACPT2 | |
| SCHEMBL9956243 | 0.84 | FFAR1 (0.44) | CYP2D6TSHRCYP2C19HIF1ACPT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230174454-A1 | PROCESS OF SYNTHESIZING AND PURIFYING (3R)-HYDROXYBUTYL (3R)-HYDROXYBUTANOATE | GENOMATICA, INC. | 2023-06-08 | — | — | US | disclosed |
| EP-4149918-A1 | PROCESS OF SYNTHESIZING AND PURIFYING (3R)-HYDROXYBUTYL (3R)-HYDROXYBUTANOATE | Genomatica, Inc. (US) | 2023-03-22 | — | — | EP | disclosed |
| WO-2021231271-A1 | PROCESS OF SYNTHESIZING AND PURIFYING (3R)-HYDROXYBUTYL (3R)-HYDROXYBUTANOATE | GENOMATICA, INC. (US) | 2021-11-18 | — | — | WO | disclosed |
| EP-3559113-A1 | MASTERBATCH COMPOSITION | Basell Poliolefine Italia S.r.l. (IT) | 2019-10-30 | — | — | EP | disclosed |
| EP-3506746-A1 | DISSOLVENT COMPOSITION, STABLE UNDER COLD CONDITIONS | OLEON NV (BE) | 2019-07-10 | — | — | EP | disclosed |
| WO-2018117271-A1 | MASTERBATCH COMPOSITION | SUNALLOMER LTD. (JP) | 2018-06-28 | — | — | WO | disclosed |
| WO-2018041886-A1 | DISSOLVENT COMPOSITION, STABLE UNDER COLD CONDITIONS | OLEON NV (BE) | 2018-03-08 | — | — | WO | disclosed |
| EP-2554049-B1 | Herbicidal composition with improved efficiency, preparation method and use | ARD SA (FR) | 2016-03-02 | — | — | EP | disclosed |
| EP-2554049-A1 | Herbicidal composition with improved efficiency, preparation method and use | AGRO INDUSTRIE RECHERCHES ET DEVELOPPEMENTS (A.R.D.) (FR) | 2013-02-06 | — | — | EP | disclosed |
| EP-1525231-A1 | CATALYST SYSTEM FOR THE POLYMERIZATION OF OLEFINS | Basell Poliolefine Italia S.P.A. (IT) | 2005-04-27 | — | — | EP | disclosed |
| WO-2004005359-A1 | CATALYST SYSTEM FOR THE POLYMERIZATION OF OLEFINS | BASELL POLIOLEFINE ITALIA S.P.A. (IT) | 2004-01-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230174454-A1 | PROCESS OF SYNTHESIZING AND PURIFYING (3R)-HYDROXYBUTYL (3R)-HYDROXYBUTANOATE | CYP8B1, GRHPR, HCAR3 | CYP2D6 1075/4885TSHR 1472/4885CYP2C19 2017/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.